Drug Interaction Report

Trospium / Xanomeline and Ivacaftor: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Ivacaftor

Kalydeco
+

Trospium / Xanomeline

Cobenfy
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Moderate
Can be significant — usually manageable with monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 122 documented Trospium / Xanomeline interactions, 79 are rated moderate — including this one.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Xanomeline (in Cobenfy) may modestly raise ivacaftor levels by slowing its breakdown in the gut, so watch for stronger ivacaftor side effects and tell your care team, but keep taking both as prescribed.

You're taking Cobenfy (which contains xanomeline and trospium) along with Kalydeco (ivacaftor). Here's the simple version: the xanomeline part can briefly slow down an enzyme in your gut called CYP3A4. That enzyme helps break down ivacaftor. When it's slowed, a little more ivacaftor may be absorbed, so its effects (and possible side effects like headache, stomach upset, or dizziness) could be a bit stronger.

This is a theoretical concern, meaning it's based on how the drugs work rather than proven problems. Please keep taking both as prescribed, and your care team can watch for any new or stronger side effects and adjust things if needed.

Direction: Xanomeline (in Cobenfy) transiently inhibits intestinal CYP3A4 without meaningful systemic inhibition. Ivacaftor is a sensitive oral CYP3A4 substrate, so co-administration may increase ivacaftor exposure (AUC/Cmax) and the frequency/severity of substrate-related adverse effects.

  • Mechanism: gut-level CYP3A4 inhibition of ivacaftor metabolism.
  • Evidence: theoretical.
  • Onset: unspecified.
  • Severity: moderate.
  • Management: continue both as prescribed; monitor for increased ivacaftor adverse effects (headache, GI upset, dizziness, transaminase elevations). Dose may be individualized by the care team if needed.
Onset
unspecified
Evidence
theoretical
Severity
Moderate

What happens

Increased oral sensitive CYP3A4 substrate exposure and an increased risk on severity and frequency of sensitive CYP3A4 substrate-related adverse reactions

Interaction Deep Dive

In the gut, xanomeline produces a transient, local inhibition of CYP3A4, though this effect does not extend systemically. When xanomeline is taken together with oral medications that are sensitive substrates of CYP3A4, exposure to those oral sensitive substrates may rise. Such an increase can heighten how often and/or how severely adverse reactions occur with those substrates. Should the two be used together, watch patients for a greater frequency and/or severity of adverse reactions tied to oral drugs that are sensitive substrates of CYP3A41.

Why it happens (mechanism)

Inhibition of CYP3A4-substrate metabolism by xanomeline

How to manage this interaction

Good news: this is usually manageable, and you should keep taking both medications as prescribed unless your prescriber tells you otherwise.

  • Watch for stronger side effects from ivacaftor, such as headache, nausea, stomach upset, or dizziness.
  • Report new or worsening symptoms to your pharmacist or doctor promptly.
  • Your care team may monitor you more closely and can individualize your dose if that becomes necessary.
  • Keep an up-to-date medication list so every provider knows you take both.

Because this concern is theoretical, no routine dose change is required, but your team can tailor things if you notice a difference.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Trospium / Xanomeline and Ivacaftor together?

Xanomeline (in Cobenfy) may modestly raise ivacaftor levels by slowing its breakdown in the gut, so watch for stronger ivacaftor side effects and tell your care team, but keep taking both as prescribed. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Trospium / Xanomeline and Ivacaftor interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Trospium / Xanomeline and Ivacaftor interaction managed?

Good news: this is usually manageable, and you should keep taking both medications as prescribed unless your prescriber tells you otherwise. Watch for stronger side effects from ivacaftor, such as headache, nausea, stomach upset, or dizziness. Report new or worsening symptoms to your pharmacist or doctor promptly. Your care team may monitor you more closely and can individualize your dose if that… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Trospium / Xanomeline or Ivacaftor need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

References (1)

  1. Citation #1
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.